Peter Mueller - Director, Bioxcel Therapeutics, Inc

As of May 23, 2022


What is Peter Mueller's Net Worth?

The current estimated net worth of Bioxcel Therapeutics, Inc's Director, Peter Mueller, is estimated to be about $34.96M . Peter Mueller owns about 168,320 units of Bioxcel Therapeutics, Inc common stock. In the last 4 years at Bioxcel Therapeutics, Inc, Peter Mueller has sold an estimated value of $0 worth.

What is Peter Mueller's Past Insider Trading?

Peter Mueller's largest purchase order was 8,446 units , worth over $73.84K on August 23, 2019. In total, Peter Mueller has made about 10 transactions over 4 years of their time at Bioxcel Therapeutics, Inc. Peter Mueller usually trades in May, with the busiest year in 2019 and 2018. The most recent transaction was a purchase order of 1,554 units , worth over $14.51K on August 26, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Bioxcel Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Vimal Mehta, Ph.D. 2020 $890,000 - $8,122,500 $556,250 $7,800 $9,576,550
Vimal Mehta, Ph.D. 2019 $459,000 - $1,269,131 $233,000 $7,800 $1,968,931
William P. Kane, Jr. 2020 $245,455 - $4,185,500 $138,699 - $4,569,654
Reina Benabou, M.D., Ph.D. 2020 $197,443 - $2,462,400 $76,341 - $2,736,184
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm

What are Bioxcel Therapeutics, Inc's Past Insider Trades?

Bioxcel Therapeutics, Inc's most recent insider trade came on June 29, 2021 by Vimal Mehta who sold 473,250 units worth $14.59M . In the last 3 years, insiders at Bioxcel Therapeutics, Inc have sold an estimated value of $131.43M and bought an estimated value of $19.96M worth of shares. Insider trading is most common in March and May, with the busiest year in 2021. The most active traders at the company are Vimal Mehta, CEO and President,  Frank Yocca, Chief Scientific Officer,  and Peter Mueller, Director .

BioXcel Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1